Alembic, Aurobindo recall drugs in US market

​​​ As per the US health regulator's latest Enforcement Report, the US-based subsidiary of Alembic Pharmaceuticals is recalling 82,400 bottles of Tobramycin Ophthalmic Solution in the American market.

Generic drugs issue: Health minister Mansukh Mandaviya to meet IMA, NMC brass today

The meeting called by the minister will be attended by the national president and two other representatives from IMA. The chairman of the National Medical Commission, Union health secretary and the director general of Indian Pharmaceutical Alliance will also be present.

USFDA approves Regeneron's ultra-rare blood disease drug

Veopoz - the first treatment to be approved by the U.S. Food and Drug Administration for the life-threatening disease - will be sold in the U.S. at a list price of $34,615.38 per single-use vial, the company told Reuters in an emailed response.